Medicine
Escitalopram 5 mg tablet
Escitalopram 5 mg tablet is a generic prescription medicine for oral use, made by 27 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59°…
Key facts
- Active ingredient (INN)
- Escitalopram
- Brand
- Sold under the generic name
- Strength
- 5 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 100 tablets, 1000 tablets, 500 tablets and 87 more
- Manufacturers
- Aurobindo PharmaIndiaCiplaIndiaTorrent PharmaceuticalsIndiaJubilant Cadista PharmaceuticalsIndiaMacleods PharmaceuticalsIndiaAccord HealthcareIndiaExelan PharmaceuticalsAmneal PharmaceuticalsAmneal Pharmaceuticals of New YorkAscent Pharmaceuticals27 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- N06AB10 Escitalopram
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 10 September 2012
- Identifiers
- RxCUI 349332, 351249, 351250DailyMed set ID d8e22060-4d06-42bf-a881-caaf65ecc3e3, 9b0b3c54-5bbc-4db9-9c69-00dac1347f24, 2957a003-7714-4e16-aeca-623fd6c5d702 +31NDC 82009-035, 50090-5312, 76420-721 +31Application ANDA090939, ANDA078032, ANDA090432 +8
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 27 labelers. The register lists 90 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, film coated in 1 bottle | 16729-168-01 | Accord HealthcareIndia | 5 March 2013 |
| 1000 tablet, film coated in 1 bottle | 16729-168-17 | Accord HealthcareIndia | 23 July 2014 |
| 100 tablet, film coated in 1 bottle | 65862-373-01 | Aurobindo PharmaIndia | 11 September 2012 |
| 500 tablet, film coated in 1 bottle | 65862-373-05 | Aurobindo PharmaIndia | 11 September 2012 |
| 10 blister pack in 1 carton / 10 tablet, film coated in 1 blister pack | 65862-373-10 | Aurobindo PharmaIndia | 11 September 2012 |
| 10000 tablet, film coated in 1 bottle | 65862-373-19 | Aurobindo PharmaIndia | 11 September 2012 |
| 30 tablet, film coated in 1 bottle | 65862-373-30 | Aurobindo PharmaIndia | 11 September 2012 |
| 90 tablet, film coated in 1 bottle | 65862-373-90 | Aurobindo PharmaIndia | 11 September 2012 |
| 30 tablet, film coated in 1 bottle | 69097-847-02 | CiplaIndia | 16 June 2016 |
| 90 tablet, film coated in 1 bottle | 69097-847-05 | CiplaIndia | 16 June 2016 |
| 100 tablet, film coated in 1 bottle | 69097-847-07 | CiplaIndia | 16 June 2016 |
| 500 tablet, film coated in 1 bottle | 69097-847-12 | CiplaIndia | 16 June 2016 |
| 1000 tablet, film coated in 1 bottle | 69097-847-15 | CiplaIndia | 16 June 2016 |
| 100 tablet, film coated in 1 bottle | 59746-279-01 | Jubilant Cadista PharmaceuticalsIndia | 1 January 2024 |
| 500 tablet, film coated in 1 bottle | 59746-279-05 | Jubilant Cadista PharmaceuticalsIndia | 1 January 2024 |
| 1000 tablet, film coated in 1 bottle | 59746-279-10 | Jubilant Cadista PharmaceuticalsIndia | 1 January 2024 |
| 30 tablet, film coated in 1 bottle | 59746-279-30 | Jubilant Cadista PharmaceuticalsIndia | 1 January 2024 |
| 100 tablet, film coated in 1 bottle | 33342-036-11 | Macleods PharmaceuticalsIndia | 11 September 2012 |
| 100 tablet, film coated in 1 carton | 33342-036-12 | Macleods PharmaceuticalsIndia | 11 September 2012 |
| 500 tablet, film coated in 1 bottle | 33342-036-15 | Macleods PharmaceuticalsIndia | 9 September 2015 |
| 100 tablet, film coated in 1 bottle | 13668-135-01 | Torrent PharmaceuticalsIndia | 11 September 2012 |
| 500 tablet, film coated in 1 bottle | 13668-135-05 | Torrent PharmaceuticalsIndia | 11 September 2012 |
| 1000 tablet, film coated in 1 bottle | 13668-135-10 | Torrent PharmaceuticalsIndia | 11 September 2012 |
| 30 tablet, film coated in 1 bottle | 13668-135-30 | Torrent PharmaceuticalsIndia | 11 September 2012 |
| 4000 tablet, film coated in 1 bottle | 13668-135-40 | Torrent PharmaceuticalsIndia | 11 September 2012 |
| 30 tablet, film coated in 1 bottle | 65162-019-03 | Amneal Pharmaceuticals | 17 May 2017 |
| 90 tablet, film coated in 1 bottle | 65162-019-09 | Amneal Pharmaceuticals | 17 May 2017 |
| 1000 tablet, film coated in 1 bottle | 65162-019-11 | Amneal Pharmaceuticals | 17 May 2017 |
| 500 tablet, film coated in 1 bottle | 65162-019-50 | Amneal Pharmaceuticals | 17 May 2017 |
| 500 tablet, film coated in 1 bottle | 53746-019-05 | Amneal Pharmaceuticals of New York | 17 May 2017 |
| 1000 tablet, film coated in 1 bottle | 53746-019-10 | Amneal Pharmaceuticals of New York | 17 May 2017 |
| 30 tablet, film coated in 1 bottle | 53746-019-30 | Amneal Pharmaceuticals of New York | 17 May 2017 |
| 90 tablet, film coated in 1 bottle | 53746-019-90 | Amneal Pharmaceuticals of New York | 17 May 2017 |
| 1000 tablet in 1 bottle | 43602-473-10 | Ascent Pharmaceuticals | 15 July 2025 |
| 30 tablet in 1 bottle | 43602-473-30 | Ascent Pharmaceuticals | 15 July 2025 |
| 100 tablet, film coated in 1 bottle | 76282-249-01 | Exelan Pharmaceuticals | 1 October 2012 |
| 500 tablet, film coated in 1 bottle | 76282-249-05 | Exelan Pharmaceuticals | 1 October 2012 |
| 1000 tablet, film coated in 1 bottle | 76282-249-10 | Exelan Pharmaceuticals | 1 October 2012 |
| 30 tablet, film coated in 1 bottle | 76282-249-30 | Exelan Pharmaceuticals | 1 October 2012 |
| 90 tablet, film coated in 1 bottle | 76282-249-90 | Exelan Pharmaceuticals | 1 October 2012 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 14 August 2002 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Escitalopram 5 mg tablet.
Other strengths and forms of Escitalopram
Clinical summary
Escitalopram is a serotonin reuptake inhibitor indicated for the treatment of major depressive disorder (MDD) in adults and pediatric patients 12 years of age and older, among other approved uses. MedsAcross supplies Escitalopram for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about EscitalopramFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Lexapro prescribing information (Allergan) · U.S. National Library of Medicine, DailyMed
Need Escitalopram 5 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.